AUROPHARMA.BO
Price:
$1217.45
Market Cap:
$707.18B
Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage throu...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-01-03
Stock Exchange
BSE
Ticker
AUROPHARMA.BO
According to Aurobindo Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 696.22B. This represents a change of 2.70% compared to the average of 677.92B of the last 4 quarters.
The mean historical Enterprise Value of Aurobindo Pharma Limited over the last ten years is 463.14B. The current 696.22B Enterprise Value has changed 14.93% with respect to the historical average. Over the past ten years (40 quarters), AUROPHARMA.BO's Enterprise Value was at its highest in in the September 2024 quarter at 868.69B. The Enterprise Value was at its lowest in in the March 2020 quarter at 273.88B.
Average
463.14B
Median
450.82B
Minimum
273.82B
Maximum
684.90B
Discovering the peaks and valleys of Aurobindo Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 119.19%
Maximum Annual Enterprise Value = 684.90B
Minimum Annual Increase = -46.87%
Minimum Annual Enterprise Value = 273.82B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 661.34B | -3.44% |
| 2024 | 684.90B | 119.19% |
| 2023 | 312.47B | -18.40% |
| 2022 | 382.94B | -25.79% |
| 2021 | 516.04B | 88.46% |
| 2020 | 273.82B | -46.87% |
| 2019 | 515.36B | 34.59% |
| 2018 | 382.92B | -9.67% |
| 2017 | 423.90B | -11.27% |
| 2016 | 477.75B | 20.51% |
The current Enterprise Value of Aurobindo Pharma Limited (AUROPHARMA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
552.90B
5-year avg
511.54B
10-year avg
463.14B
Aurobindo Pharma Limited’s Enterprise Value is less than Alkem Laboratories Limited (699.89B), less than Alkem Laboratories Limited (699.89B), greater than Abbott India Limited (610.97B), greater than Glenmark Pharmaceuticals Limited (555.43B), less than Lupin Limited (990.42B), greater than Abbott India Limited (610.97B), greater than Glenmark Pharmaceuticals Limited (555.43B), less than Lupin Limited (990.42B), greater than Laurus Labs Limited (575.43B), greater than Laurus Labs Limited (575.43B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 699.89B | $678.59B | |
| 699.89B | $680.24B | |
| 610.97B | $613.45B | |
| 555.43B | $555.43B | |
| 990.42B | $958.13B | |
| 610.97B | $615.06B | |
| 555.43B | $554.74B | |
| 990.42B | $958.65B | |
| 575.43B | $553.95B | |
| 575.43B | $553.83B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurobindo Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aurobindo Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Aurobindo Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for Aurobindo Pharma Limited (AUROPHARMA.BO)?
What is the 3-year average Enterprise Value for Aurobindo Pharma Limited (AUROPHARMA.BO)?
What is the 5-year average Enterprise Value for Aurobindo Pharma Limited (AUROPHARMA.BO)?
How does the current Enterprise Value for Aurobindo Pharma Limited (AUROPHARMA.BO) compare to its historical average?